Redwood City, CA, United States of America

Ouriel Caen

This inventor holds 2 USPTO granted patents. Top assignee: Cellanome, Inc.. Active years: 2026.


Average Co-Inventor Count = 8.0

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ouriel Caen: Innovator in Flow Cell Technology

Introduction

Ouriel Caen is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of technology, particularly with his innovative work on flow cell systems. With a focus on advancing scientific applications, Caen has secured a patent that showcases his expertise and creativity.

Latest Patents

Ouriel Caen holds a patent for a flow cell, which is a critical component in various scientific and industrial applications. This invention demonstrates his ability to address complex challenges in the field and provides a foundation for further advancements in technology. He has 1 patent to his name, reflecting his commitment to innovation.

Career Highlights

Caen is currently employed at Cellanome, Inc., where he continues to develop and refine his inventions. His role at the company allows him to collaborate with other talented professionals and contribute to cutting-edge research and development. His work is instrumental in pushing the boundaries of what is possible in flow cell technology.

Collaborations

One of his notable coworkers is Behnam Javanmardi. Together, they work on various projects that aim to enhance the functionality and efficiency of flow cell systems. Their collaboration exemplifies the importance of teamwork in driving innovation forward.

Conclusion

Ouriel Caen is a dedicated inventor whose work in flow cell technology has the potential to impact various industries. His patent and ongoing contributions at Cellanome, Inc. highlight his commitment to innovation and excellence in his field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…